HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Homologous Transplantation

Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.
Also Known As:
Transplantation, Homologous; Allogeneic Grafting; Allogeneic Transplantation; Allografting; Homografting; Grafting, Allogeneic; Transplantation, Allogeneic
Networked: 1845 relevant articles (185 outcomes, 130 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1. Hamadani, Mehdi: 26 articles (01/2022 - 04/2008)
2. Lazarus, Hillard M: 25 articles (11/2021 - 04/2006)
3. Kröger, Nicolaus: 22 articles (01/2020 - 03/2002)
4. Blaise, Didier: 21 articles (01/2022 - 07/2003)
5. Corradini, Paolo: 18 articles (01/2022 - 01/2002)
6. Kharfan-Dabaja, Mohamed A: 18 articles (01/2022 - 10/2010)
7. Sureda, Anna: 18 articles (01/2022 - 02/2004)
8. Mohty, Mohamad: 18 articles (01/2021 - 07/2003)
9. Nishihori, Taiga: 17 articles (07/2022 - 10/2010)
10. Bruno, Benedetto: 17 articles (01/2022 - 11/2003)

Related Diseases

1. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
2. Leukemia
3. Neoplasms (Cancer)
01/01/2021 - "Subsequent allogeneic transplantation was successful in eradicating the tumor clone and achieving deep molecular remission. "
10/01/2004 - "The following is now clear: for the successful engraftment of allogeneic HSC, bone marrow ablation of the recipient is not required; HSCs create their own space through graft-versus-host reactions; several malignancies can be eradicated by the graft-versus-tumour effect; HSC allografting can be conducted on an out-patient basis; HSC allografting can be done in aged or debilitated individuals; HSC allografting can be achieved without transfusion of blood products; and the costs of the allografting procedures can be substantially diminished. "
11/01/2003 - "We now have the following information: a) successful engraftment if allogeneic HSC bone marrow ablation of the recipient is not required; b) HSC create their own space through graft-vs.-host reactions; c) several malignancies are eradicated by the graft-vs.-tumor effect; d) allografting can be conducted on an out-patient basis; e) allografting can be done in aged or debilitated individuals; f) allografting can be achieved without transfusion of blood products, and g) costs of the allografting procedures can be substantially diminished. "
03/01/2000 - "Use of a tumor-free stem-cell product through improved purging or allogeneic stem cells is one approach, although the morbidity and mortality of allogeneic transplantation remain high. "
01/01/2000 - "Considering the efficacy of donor lymphocyte infusions in inducing responses in several hematologic neoplasias post allogeneic transplantation, as will be described in detail in this review, it is justified to anticipate an increasing role for this modality of treatment in relapsed non transplanted patients and as maintenance of the responses achieved with chemotherapy at conventional or high doses."
4. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
5. Multiple Myeloma

Related Drugs and Biologics

1. fludarabine
2. Busulfan (Busulfex)
3. Cyclosporine (Ciclosporin)
4. Imatinib Mesylate (Gleevec)
5. Bortezomib (Velcade)
6. Melphalan (Alkeran)
7. Granulocyte Colony-Stimulating Factor (G-CSF)
8. Antilymphocyte Serum (Anti-Thymocyte Globulin)
9. Tyrosine Kinase Inhibitors
10. Azacitidine (5 Azacytidine)

Related Therapies and Procedures

1. Therapeutics
2. Autologous Transplantation
3. Transplantation
4. Drug Therapy (Chemotherapy)
5. Stem Cell Transplantation